test

Oleg Nodelman

@Ecor1 Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
KROSKeros Therapeutics Inc
Recent Activity
0.38%
$10.888M
187,500 shares@ $58.07 avg price
REPLReplimune Group Inc
Recent Activity
0.32%
$9.32M
850,341 shares@ $10.96 avg price
ALVRAllovir Inc
Recent Activity
0.32%
$9.132M
11.295M shares@ $0.81 avg price
LENZLenz Therapeutics Inc
Recent Activity
Decreased -71.57%
0.29%
$8.232M
346,772 shares@ $23.74 avg price
VERVVerve Therapeutics Inc
Recent Activity
0.21%
$6.05M
1.25M shares@ $4.84 avg price
GBIOGeneration Bio Co
Recent Activity
0.18%
$5.056M
2.047M shares@ $2.47 avg price
ETONEton Pharmaceuticals Inc
Recent Activity
New Position
0.17%
$4.764M
794,075 shares@ $6.0 avg price
GLPGGalapagos Nv
Recent Activity
Decreased -97.3%
0.16%
$4.463M
155,006 shares@ $28.8 avg price
BBIOBridgebio Pharma Inc
Recent Activity
New Position
0.15%
$4.333M
170,172 shares@ $25.46 avg price
ATRAAtara Biotherapeutics Inc
Recent Activity
Increased 15.31%
0.14%
$3.812M
468,938 shares@ $8.14 avg price